29
Dec
Global Biosimilar Markets: Europe vs United States - How Regulation and Adoption Diverge
Europe led the biosimilar market since 2006 with clear regulations and fast adoption. The US lagged due to patent battles and strict rules-until 2024, when the FDA changed course. Now, both regions are racing to bring affordable biologic treatments to patients.